Phase 1 study of the antibody-drug conjugate SGN-LIV1A in patients with heavily pretreated triple-negative metastatic breast cancer Meeting Abstract
| Authors: | Modi, S.; Pusztai, L.; Forero, A.; Mita, M.; Miller, K. D.; Weise, A.; Krop, I.; Burris, H. 3rd; Kalinsky, K.; Tsai, M.; Liu, M. C.; Hurvitz, S. A.; Wilks, S.; Ademuyiwa, F.; Diab, S.; Han, H. S.; Kato, G.; Nanda, R.; O'Shaughnessy, J.; Kostic, A.; Li, M.; Specht, J. |
| Abstract Title: | Phase 1 study of the antibody-drug conjugate SGN-LIV1A in patients with heavily pretreated triple-negative metastatic breast cancer |
| Meeting Title: | 40th Annual San Antonio Breast Cancer Symposium (SABCS 2017) |
| Journal Title: | Cancer Research |
| Volume: | 78 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2017 Dec 5-9 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2018-02-01 |
| Language: | English |
| ACCESSION: | WOS:000425489402244 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.SABCS17-PD3-14 |
| Notes: | Meeting Abstract: PD3-14 -- Source: Wos |
